General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Hutchison China MediTech is an integrated biopharmaceutical company in China focused on innovative oncology therapies.
CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.
Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.
Ocumension is a clinical-stage biotechnology platform company focused on developing and commercializing innovative ophthalmology therapeutics in China.
Asia Medical ×
Hong Kong Asia Medical Holding Limited is a leading privately-owned Chinese healthcare services provider and hospital operator specializing in cardiology.